Infection with human immunodeficiency virus (HIV) clade C is the most common HIV infection worldwide, yet its impact on the nervous system remains largely unknown. Autopsy studies from regions affected by this virus are scarce, and HIV dementia has only rarely been reported from these countries. Most patients who develop neurologic complications die of opportunistic infections. We thus conducted a neuropathologic study from a single institution in India to characterize the HIV-infected cells in the inflammatory infiltrates in a total of 15 cases (5 patients each who died of either CNS toxoplasmosis, tuberculosis, or cryptococcal meningitis). Nearly, all patients had HIV-infected cells in the brain, although these cells were most abundant in patients with toxoplasma encephalitis. Interestingly, none of the patients had any multinucleated giant cells. HIV-infected cells were found in the parenchyma, perivascular regions, and choroid plexus and found infiltrating the parenchyma from the meninges, suggesting multiple portals of entry into the brain. These findings suggest the possibility that patients, even if successfully treated for an opportunistic inflection, may be at high risk of developing HIV encephalitis and subsequent dementia.
INTRODUCTION
Currently, the largest populations of human immunodeficiency virus (HIV)-infected patients are in Africa and Asia where there continues to be a steady increase in prevalence. However, the neurologic manifestations of HIV infection, the associated cognitive deficits, and neuropathologic studies in these populations have not been documented extensively. To date, only anecdotal reports of HIV dementia exist in this population (1Y3), with opportunistic infections being the most common cause of neurologic complications and a frequent cause of death. As antiretroviral drugs and appropriate therapies for opportunistic infections become more widely available in this population, more patients are expected to survive and live for extended periods of time and may manifest cognitive deficits. Tuberculous meningitis, cryptococcal meningoencephalitis, and toxoplasmosis are the most common CNS opportunistic infections. These infections are associated with breakdown of the blood-brain barrier and with inflammatory infiltrates. It remains unknown whether these migrating inflammatory cells and the zones of altered blood-brain barrier may serve as a portal of HIV entry into the brain. If so, it may put patients at risk of developing HIV encephalitis and subsequent neurocognitive deficits including dementia.
Even though HIV clade C is the most common HIV subtype that causes infection in Africa and Asia (4) , it remains unknown whether this clade of HIV can invade the brain and whether it can cause neuronal damage that manifests as cognitive impairment. Studies from geographical regions infected with HIV clade B virus, which predominantly includes North America and Western Europe, suggest that in patients with CD4 cell counts less than 200 cells/mm 3 the incidence of HIV dementia is about 20% per year (5) . Neuropathologic and experimental studies suggest that HIV-infected macrophages/microglia and activated but uninfected macrophages and glial cells are the principal mediators of HIV encephalitis and dementia; the neuropathologic substrate being multifocal microglial nodules and multinucleated giant cells containing viral particles (6) , with neuronal damage being a secondary event.
HIV clade C is a CCR5 tropic virus and readily infects macrophages. Similarly, all simian immunodeficiency virus strains that cause encephalitis are also CCR5 tropic. Hence, one would expect that the incidence of HIV encephalitis and dementia should be much higher in these populations; yet it is surprising that HIV dementia is unreported in this population. Several possibilities exist for this paradox. HIV dementia maybe under-recognized, patients may die of endemic opportunistic infections such as tuberculosis before they develop severe immune suppression that is a critical factor in development of HIV dementia, or molecular and genetic factors related to the virus may be different for clade C, resulting in less dementia than is seen with clade B infection (7) . To explore these possibilities, we conducted a neuropathologic study to determine whether HIV-infected cells could be found in autopsy brain tissue from patients in India.
MATERIALS AND METHODS

Patient Population and Autopsy Tissue
We analyzed formalin-fixed, paraffin-embedded tissues from 15 patients with neurologic complications of AIDS who came to autopsy at the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. NIMHANS is a tertiary care hospital in South India where patients with neurologic diseases are referred for management. Demographics of the patients are provided in Table 1 . None of the patients had received antiretroviral therapy. In this study, 15 randomly selected patients with CNS opportunistic infections were studied (5 cases each of toxoplasma encephalitis, tuberculous meningitis, and cryptococcal meningitis). We excluded patients who had multiple CNS opportunistic infections. The diagnosis of opportunistic infections was established by appropriate histochemical and immunohistochemical stains on tissues, serologic tests on cerebrospinal fluid (CSF) and serum for antigen/antibodies and PCR. All cases were confirmed to be HIV clade C by subtype-specific PCR using unfixed, fresh-frozen tissues from the frontal lobe (8) . The brains were retrieved within 2 to 20 hours postmortem (after written informed consent from close relatives) and were fixed in 10% neutral buffered formalin for 4 to 6 weeks before sectioning.
Immunohistochemistry
After a preliminary screening of representative sections from different regions of brain, sections from the hippocampus were selected for the study because of its involvement in cognitive dysfunction and dementia. Histologically involvement of hippocampus by the various opportunistic infections was ascertained. Four-to 6-mm-thick sections of formalinfixed, paraffin-embedded tissues were subjected to routine stains that included hematoxylin and eosin, Luxol-fast blueperiodic acid Schiff stain for myelin together with immunohistochemistry, using monoclonal antibodies to the HIV-1 core protein p24 (1:10 dilution; DAKO) and CD68, a macrophage marker (1:50 dilution; DAKO), as described previously (9) .
RESULTS
Clinical Course of CNS Opportunistic Infections
All except 3 patients were male. The ages of the patients in the 3 groups were essentially similar with mean T SD of 33 T 6 years for patients with toxoplasmosis, 31 T 8 years for patients with tuberculous meningitis, and 38 T 8 years for patients with cryptococcal meningitis. None of the patients received antiretroviral therapy. All patients with tuberculous meningitis died within 3 weeks of onset of the neurologic symptoms. Those treated had received a combination of streptomycin 1 g, isoniazid 300 mg, rifampicin 450 mg, and pyrazinamide 1500 mg daily. Those with toxoplasma encephalitis received a combination of pyrimethamine 75 mg and sulfadoxine 1,500 mg with sulfadiazine 4 g daily. Patients with cryptococcal meningitis received intravenous amphotericin B (increased from 0.5 to 0.75 mg/kg/day to achieve a cumulative dose of 1 to 2 g) in acute phase with oral fluconazole (400 mg/day). The clinical course of the other patients was variable. The duration of illness in patients with toxoplasmosis ranged from 1 week to 3 months, whereas patients with tuberculous meningitis died within 4 days to 6 months after the onset of symptoms (Table 1) .
Human Immunodeficiency Virus-Associated Infiltrates With CNS Toxoplasmosis HIV viral antigen was detectable by immunocytochemistry in nearly all cases (14 of 15) examined in this study. However, the pattern of immunostaining varied between the patient groups ( Table 2 ). To determine whether HIV-infected cells were associated with the inflammatory infiltrates in conjunction with CNS toxoplasmosis and the relationship between the HIV-infected cells and Toxoplasma gondii, we selected 5 patients with HIV infection who had died of CNS toxoplasmosis. Each of these patients had widespread multiple toxoplasma abscesses in the brain and had received antitoxoplasma therapy ranging from 0 to 4 days. In 2 of these patients the diagnosis was established only at autopsy (Table 1) . Patchy infiltrates of HIV-infected cells were seen in the brain parenchyma away from the lesion (Fig. 1A) , whereas large microglial nodules containing HIV viral antigen were evident in close proximity to the lesions (Fig. 1B) . Dual staining for CD68 and p24 antigen confirmed that the microglial nodules were formed of predominantly macrophages that contained HIV core antigen as well (Fig. 1B, inset) . Isolated p24-positive microglia were seen diffusely infiltrating the white matter tracts in the fornix and deep white matter of the temporal cortex away from the foci of opportunistic infections. p24-positive cells were also frequently seen in perivascular locations and were most prominent in patients with toxoplasmosis (Fig. 1C) . The leptomeninges overlying the focal parenchymal toxoplasma lesions that were close to the surface had focal meningitis containing lymphocytes, plasma cells, and occasional p24 antigen-bearing macrophages. All except 1 patient with toxoplasmosis had p24 antigen within the stromal macrophages of choroid plexus (Fig. 1D) , suggesting that this may be an important portal of entry for HIV-infected macrophages in patients with CNS opportunistic infections. The cellular infiltrates were predominantly of CD68 macrophage lineage and were seen in the toxoplasma lesions surrounding necrotic areas (Fig. 1E ) and in proximity to the toxoplasma cysts (Fig. 1E , inset) but were devoid of p24 antigen. Nodular infiltrates of macrophages were also found in perivascular locations at sites distant from the toxoplasma lesions (Fig. 1F) . 
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Human Immunodeficiency Virus-Associated Infiltrates With CNS Tuberculosis
To determine whether HIV-infected cells accompany the inflammatory infiltrates of Mycobacterium tuberculosis, we selected 5 patients with HIV infection from whom tuberculi had been isolated from the CSF or had been demonstrated in the meninges at autopsy. Each of these patients had received only a short course of antituberculous therapy of less than 1 week (Table 1) . In all 5 patients studied, inflammatory infiltrates were most prominent in the leptomeninges. In the meningeal spaces, perivenular inflammatory cells were largely composed of macrophages ( Fig. 2A) . Infiltrates in these locations in all 5 cases also consisted of large numbers of HIV-infected cells ( Fig. 2B ; Table 2 ). Although dual staining was not performed, the morphology of the HIV-infected cells in the meningeal infiltrates was that of macrophages (Fig. 2C) . HIV-infected cells were also seen in the tuberculous granulomas within the subarachnoid infiltrates (Fig. 2D) . HIV-infected macrophages were also present in the choroid plexus of all 3 patients from whom sections from this location were available ( Table 2 ), suggesting that the meningeal infiltrates were probably seeded through the choroid plexus. Scattered microglial nodules with HIV-infected cells in the parenchyma were present in 4 of the patients, suggesting that HIV infection of the brain coexisted with the tuberculous meningitis. These parenchymal deposits of p24-positive cells were mostly limited to macrophages in the subpial zone bordering foci of breach in the pia-glial membrane (Fig. 2E) . Nodular collections of macrophages in the parenchyma bordered these zones with focal extension into the cortex (Fig. 2F) . However, no HIV-associated multinucleated giant cells were seen.
Human Immunodeficiency Virus-Associated Infiltrates With Cryptococcal Meningitis
To characterize the HIV-infected cells within the inflammatory infiltrates of patients with cryptococcal meningitis, we studied 5 patients who came to autopsy with cryptococcal meningitis. In each of these patients, the diagnosis had been established antemortem with appropriate laboratory tests on CSF and serum. Except for 1 patient who received antifungal therapy for 22 days, the rest received treatment for less than 10 days. As opposed to tuberculous meningitis, HIV-infected cells were only infrequently present in the meninges and could be found at this location in only 1 patient. The HIV-infected macrophages were sparse and were most commonly present in the choroid plexus and in perivascular locations (Table 2) . Parenchymal infiltration by HIV-laden microglial cells were rare and was seen only in case 15, as shown in Figure 3A and B. The inflammatory infiltrates in all patients in this group had prominent macrophage infiltration of the choroid plexus much more so than with the other opportunistic infections described above (Fig. 3D) . Some of these macrophages were noted to phagocytose cryptococci (Fig. 3C ) but did not stain for HIV antigen. They were also present in subpial locations (Fig. 3E) .
DISCUSSION
In India as in sub-Saharan Africa, opportunistic infections remain the most common complication of AIDS. Of 134 AIDS cases autopsied over the last 15 years at NIMHANS, infections by Cryptococcus neoformans, M. tuberculosis and T. gondii have been the most prevalent (2, 10) . In these countries, CNS opportunistic infections are frequently the presenting manifestation of HIV infection. Although it is imperative that opportunistic infections be aggressively treated, the issues surrounding the use of antiretroviral drugs are more complex. Because of limited resources, it is important to identify the patients at the greatest risk for long-term neurologic complications from HIV infection. Even in countries where antiretroviral drugs are easily available, therapy is often initiated only on an outpatient basis after recovery from the acute illness. Hence, it is important to determine whether HIV-infected cells infiltrate the brain during the course of an opportunistic infection and how soon after the illness that may occur. It is also important to determine whether the various opportunistic infections vary in their ability to facilitate infiltration of HIV-infected cells into the brain. In this study, we characterized the HIV-infected cells in inflammatory infiltrates associated with these opportunistic infections. Surprisingly, we found that HIV-infected macrophages were present in nearly all patients irrespective of the type or duration of the opportunistic infection. Several patients died soon after the onset of the opportunistic infection, suggesting that HIV-infected cells enter the brain early in the course of the illness or were present prior to the opportunistic infection. The impact of treatment of the opportunistic infection on the presence of these HIV-infected cells was difficult to access from this study because most patients received treatment only for a short duration. However, in the few patients who did receive prolonged treatment, no major differences in the numbers or pattern of HIVinfected cells were noted, suggesting that whereas the opportunistic infection promotes the entry of HIV into the brain, its subsequent course may not be impacted by treatment of the opportunistic infection. It is also possible that early and aggressive treatment of the opportunistic infection may prevent further ingress of HIV-infected cells into the CNS.
The mechanism of HIV entry into the brain is most often discussed in the context of breakdown of the bloodbrain barrier and subsequent entry of the HIV-infected cells into the brain parenchyma. However, in this study we found that in all 3 types of opportunistic infections, HIV-infected cells were frequently present in the choroid plexus and the meninges. Interestingly, although infiltration of the choroid plexus was most prominent in patients with cryptococcal meningitis, meningeal infiltration was most prominent in patients with tuberculous meningitis. Even patients with toxoplasmosis had a few HIV-infected cells in the meninges. Conversely, patients with cryptococcal meningitis had only rare HIV-infected cells in the meninges. This finding probably represents a general lack of immune response in patients with cryptococcal meningitis. Importantly, however, in these patients with opportunistic infections, subpial infiltration of HIV-infected macrophages was seen, suggesting that this may be an important mode of viral entry into the brain that has not received attention previously.
Patients with cerebral toxoplasmosis had the largest amounts of HIV-infected cells that were prominent in regions surrounding the foci of toxoplasma encephalitis, perivascularly, or in organized microglial nodules. HIV-infected cells could also be found in the brain parenchyma at sites distant from the focus of overt opportunistic infection. This finding is consistent with the fact that T. gondii invades the brain parenchyma and is frequently present in the subcortical white matter and basal ganglia (11) . Hence, it is likely that HIV-infected cells accompany the inflammatory infiltrate and that once they gain access to the brain they may spread to other regions within the brain or organize themselves into microglial nodules. In patients with tuberculosis, the HIVinfected cells were most prominent in the meningeal infiltrate. Macrophages are an important component of the inflammatory infiltrate in patients with CNS tuberculosis. These cells aggregate to form granulomas and sometimes fuse to transform into Langhans giant cells and can also form granulomas, which are less frequently seen in immunocompromised patients (10) . Consistent with this observation, we noticed only an occasional granuloma and no Langhans giant cells. Patients with cryptococcal meningitis had the least amount of inflammatory infiltrates. Similar to patients with tuberculous meningitis, these patients also had HIV-infected cells in the choroid plexus, suggesting that this may be the route of entry for HIV into the CSF. The paucity of immune response in cases of cryptococcal meningitis is in keeping with the antichemotactic and anti-inflammatory properties of the cryptococcal polysaccharide capsule and independent of HIV-associated immunosuppression.
HIV infection was only found in macrophages and microglial cells. We used an antibody to the HIV core antigen p24 for immunostaining, which recognizes only cells productively infected with the virus. It thus remains unknown whether other cell types such as astrocytes can also be infected by HIV clade C virus. Astrocytes have been shown to be latently infected with HIV clade B virus. During this phase, only nonstructural proteins such as Nef are expressed (12) .
HIV-related multinucleated giant cells were not found in any of the cases studied. The absence of multinucleated giant cells in other patients with opportunistic infections suggests that either penetration of the CNS with HIVinfected cells alone is insufficient to form multinucleated giant cells or that it takes several months for multinucleated giant cells to form, once HIV infection is established within the brain. It is also possible that the clade C viruses do not as readily induce formation of multinucleated giant cells in keeping with the non-syncytium-inducing property in vitro. Macrophages were the major component of the inflammatory infiltrate in each of the opportunistic infections studied. This finding could have important implications because infiltrating HIV-infected macrophages have long been proposed to play a role as carriers of the HIV into the nervous system (13) . In fact, in some patients there were large numbers of HIV-infected macrophages in the inflammatory infiltrate. As HIV clade C uses CCR5 almost exclusively as its coreceptor (14) and hence predominantly and efficiently infects macrophages, it is likely that persistence of these cells in the CNS would have devastating effects on the brain.
Interestingly, the HIV-infected macrophages did not costain for any of the organisms causing the opportunistic infections, even when they were in close proximity to the focus of infection. This finding may suggest that the phagocytic properties of the HIV-infected cells are impaired. These observations are consistent with in vitro studies showing impaired phagocytic activity for T. gondii and mycobacterium by HIV-infected monocytes and macrophages (15, 16) . It is possible that there may be direct interactions between the 2 organisms or the inflammatory milieu of cytokines induced by 1 organism may transactivate the replication of the other, leading to positive feedback loops. For example, macrophages activated in the presence of M. tuberculosis are highly productive sources of HIV replication (17) . Several studies have demonstrated that M. tuberculosis and its cell wall components induce HIV replication in vitro (18Y20), enhance viral infectivity of monocytes (21) , and increase transmission of HIV from monocytes to lymphocytes (22) . Development of active tuberculosis has been associated with increases in plasma HIV viral load of up to 160-fold (23) . Antigens of T. gondii have been shown to enhance HIV replication (24) . Similarly C. neoformans induces HIV replication in vitro (25, 26) , and in vivo increased viral loads in CSF has been demonstrated (27) . Tissue macrophages productively infected with HIV could be found in fungal, bacterial, protozoal, and virusinfected tissues (28) . These observations provide compelling evidence that opportunistic infections can influence upregulation of HIV expression.
Whereas the presence of HIV-infected cells alone may be sufficient to meet the diagnostic criteria for HIV encephalitis (29) , in this study, some of the classical features of HIV encephalitis such as multifocal microglial nodules and characteristic multinucleated giant cells were not seen. This conspicuous absence of the neuropathologic correlate of HIV dementia/encephalitis at autopsy is consistent with other autopsy studies from this region (10) and parallels the low incidence of HIV dementia seen in this population (1Y3), underscoring the fact that factors other than the mere presence of the virus within the brain may be necessary to cause dementia. Infiltration of activated macrophages into the brain is believed to be a key event in the pathogenesis of dementia. The severity of dementia correlates with the degree of macrophage infiltration into the brain (30) . The recruitment of monocytes for HIV infection of the brain requires participation of the Tat protein of HIV, which acts as a chemokine either directly or indirectly via stimulation of monocyte chemoattractant protein-1 secretion by astrocytes (31, 32) . A natural mutation within the dicysteine motif of HIV clade C Tat that attenuates monocyte chemotaxis (7) without loss of its transactivation function has been identified, which might influence the low incidence of HIVassociated dementia in India (2, 33) and other countries where subtype C viruses predominate.
In summary, although there is clearly a greater need to characterize the effect of copathogens on HIV disease progression for development of targeted therapies, we have made several novel observations. We found that an important mechanism of viral entry into the brain in patients with opportunistic infections may involve trafficking through the choroid plexus into the CSF pathway and subsequent infiltration into the brain via subpial spaces, breaching the pia-glial barrier. Most importantly however, the finding of large amounts of viral antigen within the brain in conjunction with opportunistic infections in all patients raises the possibility that HIV-associated dementia may supervene once the opportunistic infection is successful treated and that early and aggressive treatment of opportunistic infections may inhibit not only opportunistic infection-induced pathology but also help limit viral burden.
